The antidepressant medicine sales in Denmark are projected to decline significantly over the period from 2024 to 2028. By the end of 2023, the value stood at USD 20 million. The forecast data show a notable year-on-year decrease in sales: a 21% decline from 2024 to 2025, a 26% decline from 2025 to 2026, a 35% decline from 2026 to 2027, and a 52% decline from 2027 to 2028. The compound annual growth rate (CAGR) for antidepressant medicine sales over the five-year period (2024-2028) is approximately -30.5%, indicating a sharp reduction in market size.
Future trends to watch for include the impact of generic drug penetration, shifts in mental health treatment protocols, and changes in healthcare policy. Additionally, advancements in alternative therapies and the development of new classes of antidepressants could influence market dynamics.
